Cerwenka A - Search Results

1

Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

Schlecker E, Fiegler N, Arnold A, Altevogt P, Rose-John S, Moldenhauer G, Sucker A, Paschen A, von Strandmann EP, Textor S, Cerwenka A. Schlecker E, et al. Among authors: cerwenka a. Cancer Res. 2014 Jul 1;74(13):3429-40. doi: 10.1158/0008-5472.CAN-13-3017. Epub 2014 Apr 29. Cancer Res. 2014. PMID: 24780758

2

Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.

Nausch N, Florin L, Hartenstein B, Angel P, Schorpp-Kistner M, Cerwenka A. Nausch N, et al. Among authors: cerwenka a. J Immunol. 2006 Jan 1;176(1):7-11. doi: 10.4049/jimmunol.176.1.7. J Immunol. 2006. PMID: 16365389

3

The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.

Paschen A, Arens N, Sucker A, Greulich-Bode KM, Fonsatti E, Gloghini A, Striegel S, Schwinn N, Carbone A, Hildenbrand R, Cerwenka A, Maio M, Schadendorf D. Paschen A, et al. Among authors: cerwenka a. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3297-305. doi: 10.1158/1078-0432.CCR-05-2174. Clin Cancer Res. 2006. PMID: 16740750

4

Identification of CLEC12B, an inhibitory receptor on myeloid cells.

Hoffmann SC, Schellack C, Textor S, Konold S, Schmitz D, Cerwenka A, Pflanz S, Watzl C. Hoffmann SC, et al. Among authors: cerwenka a. J Biol Chem. 2007 Aug 3;282(31):22370-5. doi: 10.1074/jbc.M704250200. Epub 2007 Jun 11. J Biol Chem. 2007. PMID: 17562706 Free article.

5

Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer.

Textor S, Dürst M, Jansen L, Accardi R, Tommasino M, Trunk MJ, Porgador A, Watzl C, Gissmann L, Cerwenka A. Textor S, et al. Among authors: cerwenka a. Int J Cancer. 2008 Nov 15;123(10):2343-53. doi: 10.1002/ijc.23733. Int J Cancer. 2008. PMID: 18712710 Free article.

6

Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.

Nausch N, Galani IE, Schlecker E, Cerwenka A. Nausch N, et al. Among authors: cerwenka a. Blood. 2008 Nov 15;112(10):4080-9. doi: 10.1182/blood-2008-03-143776. Epub 2008 Aug 27. Blood. 2008. PMID: 18753637 Free PMC article.

7

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.

Wendel M, Galani IE, Suri-Payer E, Cerwenka A. Wendel M, et al. Among authors: cerwenka a. Cancer Res. 2008 Oct 15;68(20):8437-45. doi: 10.1158/0008-5472.CAN-08-1440. Cancer Res. 2008. PMID: 18922917

8

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.

Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A. Schwinn N, et al. Among authors: cerwenka a. Int J Cancer. 2009 Apr 1;124(7):1594-604. doi: 10.1002/ijc.24098. Int J Cancer. 2009. PMID: 19089914 Free article.

9

New twist on the regulation of NKG2D ligand expression.

Cerwenka A. Cerwenka A. J Exp Med. 2009 Feb 16;206(2):265-8. doi: 10.1084/jem.20090225. Epub 2009 Feb 9. J Exp Med. 2009. PMID: 19204110 Free PMC article.

10

Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, Cerwenka A, Paschen A, Schirrmacher V, Momburg F. Jarahian M, et al. Among authors: cerwenka a. J Virol. 2009 Aug;83(16):8108-21. doi: 10.1128/JVI.00211-09. Epub 2009 Jun 10. J Virol. 2009. PMID: 19515783 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page